In This Section
How PSMA Imaging and Therapy are Changing Care for Prostate Cancer Patients - 11/9/23 - Denver
Free SNMMI Dinner Symposium: How PSMA Imaging and Therapy are Changing Care for Prostate Cancer Patients
Date: November 9, 2023
Time: 5:30 - 8:00 pm MST
Location: Ocean Prime Denver Tech Center, 8000 E. Belleview Ave. #C10, Greenwood Village, CO 80111
Fee: Complimentary
Please note that this event is now full. You are welcome to register below to join the wait list.
SNMMI has applied for 1.5 hours of CE Credit for this in-person event.
Please note that seating is limited and registration will be available on a first-come, first-served basis.
SCHEDULE
5:30 pm
Registration/Networking Reception
6:00 pm
Dinner is Served
6:30-8:00 pm
Educational Program
Several new radiopharmaceuticals are now being used in both large academic and small practice settings to stage and identify local and metastatic prostate cancer, including the recently approved Ga-68 PSMA-11, 18F-DCFPyL, and flotufolastat F 18. In addition, the FDA in March 2022 approved Lu 177 vipivotide tetraxetan to treat PSMA-positive metastatic castration-resistant prostate cancer. Given these new advancements in diagnosis and treatment, the panel will present a comprehensive, interactive session addressing the changing landscape of prostate cancer patient management.
6:30 - 6:55 pm
Welcome and Introductions/Nuclear Medicine Perspective
Bennett Chin, MD
6:55 - 7:20 pm
Oncologist's Perspective
Elizabeth (Liz) Kessler, MD
7:20 - 7:45 pm
Radiation Oncologist's Perspective
Tyler Robin, MD, PhD
7:45 - 8:00 pm
Q&A and Panel Discussion
Speakers:
Bennett Chin, MD
Professor of Radiology
Section Chief, Nuclear Medicine
University of Colorado Anschutz
Denver, CO
Elizabeth (Liz) Kessler, MD
Associate Professor of Medical Oncology
Co-Medical Director, Urologic Oncology Clinic
University of Colorado Anschutz
Denver, CO
Tyler Robin, MD, PhD
Assistant Professor of Radiation Oncology
Director of Genitourinary Radiation Oncology
University of Colorado Anschutz
Denver, CO
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. SNMMI has applied for 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. To receive CE credit, learners must complete the online assessment and evaluation available after the program.
Funding for this event includes support through a medical education grant from Cardinal Health.